Can Immunotherapy Replace Surgery for Stomach Cancer?
In a small study, just over half (59%) of patients who had combination immunotherapy showed no sign of tumor on preoperative endoscopy.
Stay updated with breaking news from I Malignancy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a small study, just over half (59%) of patients who had combination immunotherapy showed no sign of tumor on preoperative endoscopy.
Men and White people receive better treatment for gastroesophageal cancer than women, Blacks, and Latinos despite years of studies highlighting disparities in care, researchers say.
A blood test that measures circulating tumor DNA can identify patients with colorectal cancer who may derive the most benefit from adjuvant chemotherapy.
Transarterial chemoembolization (TACE) added onto lenvatinib is a new first-line option for patients with advanced liver cancer, say LAUNCH trialists.
Interim data from a large phase 3 trial show that adding durvalumab to chemotherapy significantly improved overall survival vs chemotherapy alone.